Journal of Neurochemistry,
Journal Year:
2024,
Volume and Issue:
168(5), P. 910 - 954
Published: Jan. 6, 2024
Although
we
have
learned
much
about
how
the
brain
fuels
its
functions
over
last
decades,
there
remains
still
to
discover
in
an
organ
that
is
so
complex.
This
article
lays
out
major
gaps
our
knowledge
of
interrelationships
between
metabolism
and
function,
including
biochemical,
cellular,
subcellular
aspects
functional
imaging
adult
brain,
as
well
during
development,
aging,
disease.
The
focus
on
unknowns
substrates
associated
transporters,
roles
insulin
lipid
droplets,
emerging
role
microglia,
mysteries
cofactor
signaling
molecule
NAD
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: July 12, 2023
Abstract
Studies
in
neurodegenerative
diseases,
including
Alzheimer’s
disease,
Parkinson’s
disease
and
Amyotrophic
lateral
sclerosis,
Huntington’s
so
on,
have
suggested
that
inflammation
is
not
only
a
result
of
neurodegeneration
but
also
crucial
player
this
process.
Protein
aggregates
which
are
very
common
pathological
phenomenon
can
induce
neuroinflammation
further
aggravates
protein
aggregation
neurodegeneration.
Actually,
even
happens
earlier
than
aggregation.
Neuroinflammation
induced
by
genetic
variations
CNS
cells
or
peripheral
immune
may
deposition
some
susceptible
population.
Numerous
signaling
pathways
range
been
to
be
involved
the
pathogenesis
neurodegeneration,
although
they
still
far
from
being
completely
understood.
Due
limited
success
traditional
treatment
methods,
blocking
enhancing
inflammatory
considered
promising
strategies
for
therapy
many
them
got
exciting
results
animal
models
clinical
trials.
Some
them,
few,
approved
FDA
usage.
Here
we
comprehensively
review
factors
affecting
major
pathogenicity
sclerosis.
We
summarize
current
strategies,
both
clinic,
diseases.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Aug. 16, 2023
Abstract
Mitochondria
are
dynamic
organelles
with
multiple
functions.
They
participate
in
necrotic
cell
death
and
programmed
apoptotic,
crucial
for
metabolism
survival.
Mitophagy
serves
as
a
cytoprotective
mechanism
to
remove
superfluous
or
dysfunctional
mitochondria
maintain
mitochondrial
fine-tuning
numbers
balance
intracellular
homeostasis.
Growing
evidences
show
that
mitophagy,
an
acute
tissue
stress
response,
plays
important
role
maintaining
the
health
of
network.
Since
timely
removal
abnormal
is
essential
survival,
cells
have
evolved
variety
mitophagy
pathways
ensure
can
be
activated
time
under
various
environments.
A
better
understanding
diseases
treatment
therapeutic
target
design.
In
this
review,
we
summarize
molecular
mechanisms
mitophagy-mediated
elimination,
how
maintains
homeostasis
at
system
levels
organ,
what
alterations
related
development
diseases,
including
neurological,
cardiovascular,
pulmonary,
hepatic,
renal
disease,
etc.,
recent
advances.
Finally,
potential
clinical
applications
outline
conditions
regulators
enter
trials.
Research
advances
signaling
transduction
will
developing
new
strategies
precision
medicine.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(4), P. 1989 - 1989
Published: Feb. 11, 2022
Aging
is
the
greatest
risk
factor
for
late-onset
Alzheimer’s
disease
(LOAD),
which
accounts
>95%
of
(AD)
cases.
The
mechanism
underlying
aging-related
susceptibility
to
LOAD
unknown.
Cellular
senescence,
a
state
permanent
cell
growth
arrest,
believed
contribute
importantly
aging
and
diseases,
including
AD.
Senescent
astrocytes,
microglia,
endothelial
cells,
neurons
have
been
detected
in
brain
AD
patients
animal
models.
Removing
senescent
cells
genetically
or
pharmacologically
ameliorates
β-amyloid
(Aβ)
peptide
tau-protein-induced
neuropathologies,
improves
memory
model
mice,
suggesting
pivotal
role
cellular
senescence
pathophysiology.
Nonetheless,
although
accumulated
evidence
supports
AD,
mechanisms
that
promote
how
neuropathophysiology
remain
largely
This
review
summarizes
recent
advances
this
field.
We
believe
removal
represents
promising
approach
toward
effective
treatment
such
as
Journal of Neuroinflammation,
Journal Year:
2022,
Volume and Issue:
19(1)
Published: Oct. 4, 2022
Abstract
Stimulator
of
interferons
genes
(STING),
which
is
crucial
for
the
secretion
type
I
and
proinflammatory
cytokines
in
response
to
cytosolic
nucleic
acids,
plays
a
key
role
innate
immune
system.
Studies
have
revealed
participation
STING
pathway
unregulated
inflammatory
processes,
traumatic
brain
injury
(TBI),
spinal
cord
(SCI),
subarachnoid
haemorrhage
(SAH)
hypoxic–ischaemic
encephalopathy
(HIE).
signalling
markedly
increased
CNS
injury,
agonists
might
facilitate
pathogenesis
injury.
However,
effects
STING-regulated
activation
are
not
well
understood.
Aberrant
increases
events,
interferon
responses,
cell
death.
cGAS
primary
that
induces
activation.
Herein,
we
provide
comprehensive
review
latest
findings
related
cGAS–STING
highlight
control
mechanisms
their
functions
Furthermore,
summarize
explore
most
recent
advances
toward
obtaining
an
understanding
involvement
programmed
death
(autophagy,
necroptosis,
ferroptosis
pyroptosis)
during
We
also
potential
therapeutic
agents
capable
regulating
pathway,
facilitates
our
value
this
as
treatment
target.
Proceedings of the National Academy of Sciences,
Journal Year:
2022,
Volume and Issue:
119(15)
Published: April 8, 2022
In
idiopathic
Parkinson’s
disease
(PD),
pathologic
αSyn
aggregates
drive
oxidative
and
nitrative
stress
that
may
cause
genomic
mitochondrial
DNA
damage.
These
events
are
associated
with
activation
of
the
cyclic
GMP-AMP
synthase
(cGAS)/stimulator
interferon
genes
(STING)
immune
pathway,
but
it
is
not
known
whether
STING
activated
in
or
contributes
to
α-synucleinopathies.
Herein,
we
used
primary
cell
cultures
intrastriatal
preformed
fibril
(αSyn-PFF)
mouse
model
PD
demonstrate
pathology
causes
STING-dependent
neuroinflammation
dopaminergic
neurodegeneration.
microglia-astrocyte
cultures,
αSyn-PFFs
induced
double-strand
break
(DSB)
damage
response
signaling
(γH2A.X),
as
well
TBK1
was
blocked
by
inhibition.
αSyn-PFF
model,
similarly
observed
increased
γH2A.X
within
striatal
microglia
prior
onset
Using
STING-deficient
(Stinggt)
mice,
demonstrated
α-Syn
PFF
STING-dependent.
Furthermore,
Stinggt
mice
were
protected
from
PFF-induced
motor
deficits,
accumulation,
neuron
loss.
We
also
upregulation
protein
substantia
nigra
pars
compacta
(SNpc)
human
patients
correlated
significantly
accumulation.
upregulated
treated
αSyn-PFFs,
which
primed
pathway
mount
stronger
responses
when
exposed
a
agonist.
Our
results
suggest
microglial
both
neurodegeneration
arising
α-synucleinopathies,
including
PD.